Cardiovascular outcomes after a change in prescription policy for clopidogrel
Jackevicius CA, Tu JV, Demers V, Melo M, Cox J, Rinfret S, Kalavrouziotis D, Johansen H, Behlouli H, Newman A, Pilote L. N Engl J Med. 2008; 359(17):1802-10.
Publications
Use of ezetimibe in the United States and Canada
Jackevicius CA, Tu JV, Ross JS, Ko DT, Krumholz HM. N Engl J Med. 2008; 358(17):1819-28. Epub 2008 Mar 30.
Prevalence, predictors and outcomes of primary nonadherence after acute myocardial infarction
Jackevicius CA, Li P, Tu JV. Circulation. 2008; 117(8):1028-36.
Concordance between discharge prescriptions and insurance claims in post-myocardial infarction patients
Jackevicius CA, Paterson JM, Naglie G. Pharmacoepidemiol Drug Saf. 2007; 16(2):207-15.
Acute treatment of myocardial infarction in Canada 1999-2002
Jackevicius CA, Alter D, Cox J, Daly P, Goodman S, Filate W, Newman A, Tu JV; Canadian Cardiovascular Outcomes Research Team. Can J Cardiol. 2005; 21(2):145-52.
Routine utilization of glycoprotein IIb/IIIa inhibitor therapy is associated with improved in-hospital outcome after percutaneous coronary intervention: insights from a large prospective single-centre registry
Jackevicius CA, Pinto R, Daly P, Mackie K, Dzavik V. Can J Cardiol. 2005; 21(1):27-32.
Population rates of hospitalization for atrial fibrillation/flutter in Canada
Humphries KH, Jackevicius C, Gong Y, Svensen L, Cox J, Tu JV, Laupacis A; Canadian Cardiovascular Outcomes Research Team. Can J Cardiol. 2004; 20(9):869-76.
Safety of glycoprotein IIb/IIIa inhibitors in urgent or emergency coronary artery bypass graft surgery
Cheng DK, Jackevicius CA, Seidelin P, Feindel C, Rouleau JL. Can J Cardiol. 2004; 20(2):223-8.
Secondary prevention after acute myocardial infarction in four Canadian provinces, 1997-2000
Pilote L, Beck CA, Karp I, Alter D, Austin P, Cox J, Humphries K, Jackevicius C, Richard H, Tu JV; Canadian Cardiovascular Outcomes Research Team. Can J Cardiol. 2004; 20(1):61-7.
Trends in cardiovascular drug utilization and drug expenditures in Canada between 1996 and 2001
Jackevicius CA, Tu K, Filate WA, Brien SE, Tu JV; Canadian Cardiovascular Outcomes Research Team. Can J Cardiol. 2003; 19(12):1359-66.